Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

5.460 +0.020 (+0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™... 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
Tuesday, January 9, 2024, at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Present at Stifel 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2023 Financial Results
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports First Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the Bank of America 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report First Quarter 2023 Financial Results on May 8, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Publishes Inaugural ESG Report
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via GlobeNewswire
NASDAQ:TMCI Shareholder Alert: Investigation over Potential Wrongdoing at Treace Medical Concepts, Inc.
San Diego, CA -- (SBWIRE) -- 01/27/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Treace Medical Concepts, Inc. 
Via SBWire
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.